Summary

Eligibility
for females ages 18 years and up (full criteria)
Healthy Volunteers
healthy people welcome
Location
at Fresno, California
Dates
study started
completion around
Principal Investigator
by Ushma Upadhyay, PhD, MPH

Description

Summary

The Missed Period Pill Study is a prospective observational study among people who decide to use misoprostol alone for menstrual regulation.

Official Title

Assessing the Acceptability of Using Misoprostol Alone for Menstrual Regulation

Details

As the number of state laws restricting access to abortion increases across the country, more creative methods are needed to support individuals in achieving their reproductive goals. Misoprostol alone for people who suspect, but have not confirmed pregnancy, has the potential to fulfill this growing need. The goal of this research study is to test a traditional but underutilized framework of menstrual regulation for pregnancy loss, to "bring back" a period when it is missed. This study will aim to recruit 100 patients who have a missed period to address research questions that focus on the feasibility and acceptability of using misoprostol alone for menstrual regulation.

The study will require 1 study visit and 1 telehealth visit.

First study visit: A urine sample will be collected which will later undergo pregnancy testing. Participants will be given misoprostol along with instructions and information on what to expect. The participant will be required to return to the clinic 4 weeks later to provide another urine sample. The participant will not know the results of the first visit's pregnancy test at any point. The clinic staff member administering the participant's care will not know of the pregnancy test result while the participant is at the clinic.

Telehealth visit: The second visit will be by phone or video. The participant will conduct a pregnancy test and inform the research staff of the result. The participant will then be asked to answer questions on an online survey about their experience using misoprostol.

A variety of clinical and social science measures will be collected to assess the feasibility and acceptability of this traditional concept of menstrual regulation utilizing uterine evacuation with medications.

Keywords

Menstrual Regulation, Menstrual Irregularity, late period, missed period, mensturation, Menstruation Disturbances, Misoprostol

Eligibility

You can join if…

Open to females ages 18 years and up

  • Be 18 years old or older
  • Read and speak English
  • Know the date of their last menstrual period within 2 days
  • Have a period that is late by up to 14 days
  • Have had regular periods in the last 4-6 months
  • Does not want to be pregnant; understand that if they are pregnant, the pills will end their pregnancy
  • Be willing to have an abortion if the missed period pill does not work, and informed of potential for birth defects in any ongoing pregnancy
  • Does not want to verify pregnancy status
  • Does not have risk factors for ectopic pregnancy (history of ectopic pregnancy, recent vaginal bleeding or spotting, pelvic pain on one side, prior permanent contraception, or other tubal surgery)
  • Does not have an IUD
  • Does not currently use a contraceptive implant or injectable
  • Does not have contraindications to misoprostol
  • Agree to participate in the follow up visit/call

You CAN'T join if...

  • Participants who have contraindications to misoprostol
  • Unknown date of last menstrual period
  • Risk factors for ectopic pregnancy (history of ectopic pregnancy, recent vaginal bleeding or spotting, pelvic pain on one side, prior permanent contraception, or other tubal surgery)
  • Irregular menses or any other condition that in the opinion of the Principal Investigator would compromise participant safety.

Location

  • UCSF
    Fresno California 93701 United States

Lead Scientist at UCSF

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
Links
Missed Period Pill Study Enrollment Website
ID
NCT04940013
Phase
Phase 4 Menstruation Research Study
Study Type
Interventional
Participants
Expecting 100 study participants
Last Updated